Mol Med Rep 23: [Related article:] 318, 2021; DOI:
10.3892/mmr.2021.11957
Following the publication of this article, an
interested reader drew to the authors’ attention that the primer
sequences written for lncRNA DQ786243 and miR-15b-5p on p. 2 in the
study were incorrect. Upon requesting an explanation of these
errors from the authors, they realized that, regarding the sequence
of the reverse primer for lncRNA DQ786243, three nucleotides were
omitted from its 3’-end [the sequence of this primer on p. 2,
right-hand column, line 25 should have been written as
5’-CTTCTGCTGGGCTGTTGAGTG-3’ (with the omitted nucleotides
highlighted in bold)]. Regarding the primers of miR-15b-5p, the
authors used the mature miR-15b-5p sequence as the forward primer;
however, they inadvertently overlooked replacing U with T in the
description of the forward primer of miR-15b-5p, and therefore the
sequence of the forward primer of miR-15b-5p on line 27 should have
been written as
5’-TAGCAGCACATCATGGTTTACA-3’. Moreover,
a universal reverse primer was used for the reverse primer of
miR-15b-5p, as provided by the kit [specifically, the authors used
an Mir-X miRNA qRT-PCR TB Green Kit (Takara Bio USA, Inc.) for
detecting the expression of miR-15b-5p, and the reverse primer was
supplied in the kit]; however, a different primer sequence used in
the authors’ lab was erroneously written as the reverse primer of
miR-15b-5p in the manuscript. Finally, note that the title was
published with a typographical error: “miR-15p-5p” in the title
should have been written as “miR-15b−5p”, as appeared
elsewhere throughout the paper, and the corrected title is
presented above.
The authors are grateful to the Editor of
Molecular Medicine Reports for allowing them the opportunity
to publish this corrigendum, and all the authors agree with its
publication. The authors also regret the inconvenience that these
mistakes have caused.
